Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

The impact of alcohol and its metabolites on the epigenome of astrocytes

Award Number: F31AA032407
ORGANIZATION: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 05/01/2025
PERIOD OF PERFORMANCE END DATE: 04/30/2029

Group Awards By:

View Award Description

The impact of alcohol and its metabolites on the epigenome of astrocytes - PROJECT SUMMARY Alcohol use disorder (AUD) is a global disease burden and while biological mechanisms underlying AUD have largely been examined in neurons, the role of glial cells is historically understudied. One glial cell type potentially important in AUD is astrocytes, which undergo transcriptional and functional changes upon alcohol exposure. Knowledge of how this is regulated is limited. Since astrocytes are the most abundant glial cell type in the central nervous system (CNS) and dynamically modulate neuronal activity and synaptic plasticity, it is conceivable that the impact of ethanol (EtOH) and its metabolite acetate on astrocytes may lead to both pronounced intracellular effects and subsequent downstream effects on the CNS through epigenetic mechanisms. In support of this notion, acetyl-CoA synthetase 2 (ACSS2) converts acetate to acetyl-CoA used in chromatin regulation of gene expression. Acetyl-CoA is used by histone acetyltransferases (HATs) to drive histone acetylation, which is associated with active transcription and is thought to underlie alcohol-related behaviours. However, whether acetate contributes to histone acetylation specifically in astrocytes, and whether this process is mediated by ACSS2, is unknown. Our lab has previously shown that EtOH is metabolized and deposited as acetate in the brain. During my preliminary studies, I found ACSS2 is highly expressed in and localized to the nucleus of astrocytes, suggesting an epigenetic, gene regulatory role. Treating primary astrocytes with acetate for 24 hours induced differential regulation of over 800 genes by RNA-seq. Moreover, an ACSS2 inhibitor reduced certain acetate-induced transcriptional effects. Interestingly, treating astrocytes with acetate for only 1 hour increased immediate early gene (IEG) expression, although this was not identified at 24 hours. This suggests astrocytes induce distinct waves of gene expression, which has never been directly tested in astrocytes but can importantly contribute to neuronal activity. Spatial transcriptomics analysis in vivo agrees with this, as stimulating fear memories in mice led to astrocytes upregulating certain IEGs at an early time point. Strikingly, this upregulation did not occur in full-body ACSS2 knockout mice. Based on the these evidence and models, I hypothesize that alcohol and its metabolites stimulate waves of transcription in astrocytes, where ACSS2 incorporates acetate into histone acetylation to activate genes that promote alcohol-associated behaviours. To address this hypothesis, I propose to focus on two specific aims: (1) to determine the wave-trajectory of astrocyte gene expression and the impact of alcohol and its metabolites, and (2) to determine whether astrocytes in the brain respond to alcohol metabolism by incorporating alcohol-derived acetate into histone acetylation at key DNA regulatory regions. Completion of these aims will not only reveal potential new therapeutic targets for AUD but will also unveil the capability and mechanism of astrocytes undergoing wave-trajectory of gene expression, yet to be studied. Notably, my study is different from my supervisor’s current NIAAA R01 submission under review.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $50,114 )
2026	2026	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Alcohol Research Programs	000	2	4/9/2026	NON-COMPETING CONTINUATION	$50,114
														Subtotal = $50,114

Issue Date FY: 2025 ( Subtotal = $49,538 )
2025	2025	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Alcohol Research Programs	001	1	4/24/2025	NEW	$0
2025	2025	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Alcohol Research Programs	000	1	4/24/2025	NEW	$48,974
2025	2025	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Alcohol Research Programs	002	1	6/6/2025	NEW	$564
														Subtotal = $49,538

Grand Total All Awards = $99,652

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The impact of alcohol and its metabolites on the epigenome of astrocytes

Award Number: F31AA032407

ORGANIZATION: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 05/01/2025

PERIOD OF PERFORMANCE END DATE: 04/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer